"Our Modern" announces the approval of FDA on a new vaccine to prevent CoveYyd 19

The American Moderna Drug Company announced on Saturday that the US Food and Drug Administration has agreed to its MNEXPIKE vaccine from the next generation to prevent ‘CoveYyd-19’ for all the 65-year-old individuals, in the first approval, as the administration extends the requirements. The company added in a statement that the vaccine was also approved for individuals between the ages of 12 and 64 years suffering from one or more problematic cases inherent or risk factors. The vaccine is available soon and our modernna said it expects the “Mnexspike” vaccine to be available for the 2025-2026 respiratory virus season. “The approval of the US Food and Drug Administration to our third producer, MNEXPIKE, adds a new important tool to help people protect the risk of serious diseases from Covid-19.” Under the leadership of Robert Kennedy Junior, led by the vaccine, the Ministry of Health and Humanitarian Services worked to increase the regulatory investigation of the vaccines. The US Food and Drug Administration said on May 20 that it intends to demand pharmaceutical businesses to test their reinforced doses for ‘Covid’ against an imaginary, cheap agent for healthy adults under the age of 65 for approval, which is actually limited to the elderly and those who are the risk of serious illnesses. The MnExspskik sign, in refrigerators, can be stored in refrigerators instead of frozen to provide a longer standard life and facilitate distribution, especially in developing countries where the problems of the supply chain can hinder the vaccination campaigns. Corona picks the lives of hundreds a week and more than five years after the first cases of Corona virus infection in the United States, hundreds of people are still working on the virus weekly, according to the American ABC News. In April, the average deaths in Corona reached about 350 people per week, according to the data of the Centers for Disease Control and Prevention (CDC). Despite the high deaths, the number was reduced, which is less than the peak of 25 thousand and 974 deaths and registered during the week ended January 9, 2021, in addition to the weekly deaths recorded in the previous spring months, according to the data of the Centers for Disease Control and Prevention. Network public health experts said although the United States is much better than it was a few years ago, Corona is still a threat to the risk groups. “Our continuation in seeing deaths is simply that it is still spreading, and that people are still developing it,” said Tony Modi, a professor at the Department of Pediatrics at the Department of Infectious Diseases at Medical Center at Duke University. According to experts, there are some reasons that can lead to the continued death of people due to the virus, including low demand for vaccination, poor immunity and insufficient number of people who receive treatments.